| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8714664 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 8 Pages |
Abstract
Undetectable MBL and prednisolone confer a high risk for an SI. The use of biologic DMARDs did not confer substantial SI risk in this observational study. MBL deficiency is hitherto an unrecognized risk factor for an SI in RA.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Graeme J. MD, Krista MBBS, Maxine MBBS, Max PhD, Bronwyn V. MBBS, Shona M. MBBS, Erin M. BEng, Andrew MD, Christine PhD, Monica L. MSc, Pooja MSc, Dana MBBS, Sophie PhD, Tracie MSc, James MMed, Timothy MBBS, C. Helen MSc, Michaela MD,